Literature DB >> 33558598

Structural aspects of lesional and non-lesional skin microbiota reveal key community changes in leprosy patients from India.

Nitin Bayal1, Sunil Nagpal2, Mohammed Monzoorul Haque2, Milind S Patole3, Yogesh Shouche3, Shekhar C Mande4,5, Sharmila S Mande6.   

Abstract

Although skin is the primary affected organ in Leprosy, the role of the skin microbiome in its pathogenesis is not well understood. Recent reports have shown that skin of leprosy patients (LP) harbours perturbed microbiota which grants inflammation and disease progression. Herein, we present the results of nested Polymerase Chain Reaction-Denaturing Gradient Gel Electrophoresis (PCR-DGGE) which was initially performed for investigating the diversity of bacterial communities from lesional skin (LS) and non-lesional skin (NLS) sites of LP (n = 11). Further, we performed comprehensive analysis of 16S rRNA profiles corresponding to skin samples from participants (n = 90) located in two geographical locations i.e. Hyderabad and Miraj in India. The genus Staphylococcus was observed to be one of the representative bacteria characterizing healthy controls (HC; n = 30), which in contrast was underrepresented in skin microbiota of LP. Taxa affiliated to phyla Firmicutes and Proteobacteria were found to be signatures of HC and LS, respectively. Observed diversity level changes, shifts in core microbiota, and community network structure support the evident dysbiosis in normal skin microbiota due to leprosy. Insights obtained indicate the need for exploring skin microbiota modulation as a potential therapeutic option for leprosy.

Entities:  

Year:  2021        PMID: 33558598     DOI: 10.1038/s41598-020-80533-5

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  40 in total

1.  Leprosy-like illness in a patient with Mycobacterium lepromatosis from Ontario, Canada.

Authors:  Peter G Jessamine; Marc Desjardins; Tom Gillis; David Scollard; Frances Jamieson; George Broukhanski; Pam Chedore; Anne McCarthy
Journal:  J Drugs Dermatol       Date:  2012-02       Impact factor: 2.114

Review 2.  How to reduce stigma in leprosy--a systematic literature review.

Authors:  Silatham Sermrittirong; Wim H Van Brakel; J F G Bunbers-Aelen
Journal:  Lepr Rev       Date:  2014-09       Impact factor: 0.537

Review 3.  The skin microbiome: Associations between altered microbial communities and disease.

Authors:  Laura S Weyrich; Shreya Dixit; Andrew G Farrer; Alan J Cooper; Alan J Cooper
Journal:  Australas J Dermatol       Date:  2015-02-25       Impact factor: 2.875

Review 4.  Two Cases of Leprosy in Siblings Caused by Mycobacterium lepromatosis and Review of the Literature.

Authors:  Michael C Sotiriou; Barbara M Stryjewska; Carlotta Hill
Journal:  Am J Trop Med Hyg       Date:  2016-07-11       Impact factor: 2.345

Review 5.  Skin microbiota-host interactions.

Authors:  Y Erin Chen; Michael A Fischbach; Yasmine Belkaid
Journal:  Nature       Date:  2018-01-24       Impact factor: 49.962

Review 6.  The relationship between skin function, barrier properties, and body-dependent factors.

Authors:  A K Dąbrowska; F Spano; S Derler; C Adlhart; N D Spencer; R M Rossi
Journal:  Skin Res Technol       Date:  2017-10-23       Impact factor: 2.365

Review 7.  Skin barrier and microbiome in acne.

Authors:  M A Rocha; E Bagatin
Journal:  Arch Dermatol Res       Date:  2017-11-17       Impact factor: 3.017

Review 8.  Architecture of antimicrobial skin defense.

Authors:  Kamila Kwiecien; Aneta Zegar; James Jung; Piotr Brzoza; Mateusz Kwitniewski; Urszula Godlewska; Beata Grygier; Patrycja Kwiecinska; Agnieszka Morytko; Joanna Cichy
Journal:  Cytokine Growth Factor Rev       Date:  2019-08-15       Impact factor: 7.638

Review 9.  The biology of nerve injury in leprosy.

Authors:  David M Scollard
Journal:  Lepr Rev       Date:  2008-09       Impact factor: 0.537

10.  Microbial community profiling shows dysbiosis in the lesional skin of Vitiligo subjects.

Authors:  Parul Ganju; Sunil Nagpal; M H Mohammed; P Nishal Kumar; Rajesh Pandey; Vivek T Natarajan; Sharmila S Mande; Rajesh S Gokhale
Journal:  Sci Rep       Date:  2016-01-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.